Blair Thedinger
Family Medicine · Kansas City, MONPI 1750606042
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Gilead at 43.1% of the total. 2025 is the largest year on record at $46,327, more than ten times the $65 reported in 2019. Among family medicine clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 145 payments — averaging $489.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$31K
- AbbVie$21K
- Viiv Healthcare Company$19K
- Johnson & Johnson$181
- Merck$72
- Amgen$17
- plus $12 from 1 others
Across 137 payments — averaging $8956.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Viiv Healthcare Company$1.1M
- GSK$105K
What the payments were for
- Consulting fees$25,00035%
- Speaking & faculty fees$34,70049%
- Travel & lodging$7,32410%
- Food & beverage$3,9496%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 61 | $30,563 |
| AbbVie | 35 | $20,846 |
| Viiv Healthcare Company | 33 | $19,281 |
| Johnson & Johnson | 12 | $181 |
| Merck | 2 | $72 |
| Amgen | 1 | $17 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$70,973 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 313 | $1,294,500 |
| DovatoDolutegravir Sodium/Lamivudine | 254 | $804,194 |
| EpclusaSofosbuvir/Velpatasvir | 12 | $288,934 |
| CabenuvaCabotegravir/Rilpivirine | 22 | $152,998 |
| TivicayDolutegravir Sodium | 48 | $125,429 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 32 | $114,466 |
| DescovyEmtricitabine/Tenofov Alafenam | 42 | $106,494 |
| PrezcobixDarunavir/Cobicistat | 42 | $101,765 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 20 | $88,974 |
| JulucaDolutegravir/Rilpivirine | 21 | $77,386 |
| MounjaroTirzepatide | 52 | $68,635 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 18 | $66,691 |
| OzempicSemaglutide | 56 | $63,026 |
| PifeltroDoravirine | 26 | $48,597 |
| JardianceEmpagliflozin | 45 | $47,676 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Epclusa, Descovy, Genvoya | $30,563 | $1,778,902387 claims |
| Viiv Healthcare CompanyDovato, Cabenuva, Tivicay, Juluca, Triumeq | $19,281 | $1,226,698363 claims |
| Johnson & JohnsonPrezcobix, Xarelto | $181 | $121,59565 claims |
| MerckPifeltro, Isentress Hd, Januvia | $72 | $94,04366 claims |
| PfizerEliquis | $12 | $10,18819 claims |
| AbbVieLinzess | $20,846 | $7,69314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Kansas City
- Jon MattsonKansas City$53K
- Meredith LevineKansas City$26K
- Kelly SandriKansas City$17K
- Michael SimanovskyKansas City$16K
- Teresa MarshallKansas City$16K
- Nora GomezKansas City$15K
- Julie AlvarezKansas City$15K
- Neal MooreKansas City$14K
- Stephen AdamsSpringfield$636K
- Justin PuckettKirksville$568K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.